{"result": "(\"entity\"<|>GONADOBLASTOMA<|>EVENT<|>Gonadoblastoma, also known as dysgenetic gonadoma, is a mixed tumor of the sex-cord stroma that can induce signs of virilization in young patients with gonadal dysgenesis.)\n##\n(\"entity\"<|>GONADAL INSUFFICIENCY<|>EVENT<|>Gonadal insufficiency is a condition characterized by the underdevelopment or dysfunction of the gonads, leading to low hormone levels and potential fertility issues.)\n##\n(\"entity\"<|>MOSAICISM<|>EVENT<|>Mosaicism refers to the presence of two or more genetically different cell lines within an individual, which can lead to variable expression of genetic conditions such as Turner syndrome.)\n##\n(\"entity\"<|>ANDROGENS<|>ORGANIZATION<|>Androgens are male sex hormones that play a role in the development of male characteristics and reproductive activity; their action is critical during fetal development for sexual differentiation.)\n##\n(\"entity\"<|>ANTIMULLERIAN HORMONE<|>ORGANIZATION<|>Antimüllerian hormone is produced by the Sertoli cells of the testes and is involved in male sexual differentiation by inhibiting the development of female reproductive structures.)\n##\n(\"entity\"<|>5α-REDUCTASE<|>ORGANIZATION<|>5α-reductase is an enzyme that converts testosterone into dihydrotestosterone, playing a key role in the development of male external genitalia.)\n##\n(\"relationship\"<|>GONADOBLASTOMA<|>GONADAL INSUFFICIENCY<|>Gonadoblastoma can occur in individuals with gonadal insufficiency, particularly in those with dysgenetic gonads<|>7)\n##\n(\"relationship\"<|>MOSAICISM<|>TURNER SYNDROME<|>Mosaicism can lead to variable presentations of Turner syndrome, affecting the severity of symptoms<|>6)\n##\n(\"relationship\"<|>ANDROGENS<|>ANDROGEN INSENSITIVITY SYNDROME<|>Androgens are crucial for male sexual differentiation, and their insensitivity leads to the development of female physical traits in individuals with XY chromosomes<|>9)\n##\n(\"relationship\"<|>ANTIMULLERIAN HORMONE<|>ANDROGENS<|>Antimüllerian hormone works alongside androgens during fetal development to promote male sexual differentiation<|>8)\n##\n(\"relationship\"<|>5α-REDUCTASE<|>DIHYDROTESTOSTERONE<|>5α-reductase is responsible for converting testosterone into dihydrotestosterone, which is essential for male genital development<|>9)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: del 10% de                                                       cromosómico, gonadal y fenotípico que definen la diferenciación sexual.\n              los casos, por lo que cuando está presente se recomienda la gonadectomía profilática. El\n              gonadoblastoma, conocido también como gonadoma disgenético, es un tumor mixto de los                                                    Pueden ser clasificadas en tres grupos:\n              cordones sexuales-estroma que induce algunos signos de virilización en pacientes jóvenes                                                1.  Anomalías del cromosoma sexual, como el síndrome de Turner o el síndrome de Klinefel-\n              fenotípicamente femeninas. Pueden ser bilaterales y relacionarse con tumores germinales.                                                    ter.\n              La alteración genética del síndrome de Turner se manifiesta con talla baja, insuficiencia                                               2.  Anomalías 46,XY.\n              gonadal y alteraciones          fenotípicas características, con           gran variabilidad en su expre-                               3.  Anomalías 46,XX.\n              sión.                                                                                                                                   Las anomalías de pacientes con cariotipo 46,XY incluyen alteraciones del desarrollo gona-\n              La insuficiencia gonadal es muy frecuente, pero la pubertad puede iniciarse espontánea-                                                 dal, de la síntesis androgénica, de la acción androgénica y otras.\n              mente en algunas pacientes, sobre todo si son mosaicos, lo que da la oportunidad de                                                     La causa más característica de las anomalías 46,XY por alteración de la acción androgéni-\n              preservar óvulos que permitan la fertilidad más adelante, teniendo en cuenta que pronto                                                 ca es el síndrome de insensibilidad genética a los andrógenos, por alteraciones del gen del\n              pueden perder la capacidad ovulatoria. La insuficiencia gonadal cursará con aumento de                                                  receptor androgénico (ligado al cromosoma X).\n              gonadotrofinas y con niveles de E2, hormona antimülleriana e inhibina bajos.\n              La estatura baja es el hallazgo más común, consecuencia de la falta del material del gen                                                El defecto puede ser completo o parcial, correspondiendo en el primero a un fenotipo con\n              SHOX del cromosoma X.                                                                                                                   genitales externos femeninos normales, y en el segundo a grados diversos de deficiencia\n                                                                                                                                                      androgénica en pacientes con genitales externos masculinos con trastornos más leves del\n              Aunque la secreción de la hormona del crecimiento (GH) se conserve, el tratamiento con GH                                               desarrollo sexual. La heterogénea presentación de los defectos parciales ha dado lugar a\n              recombinante está indicado porque mejora la talla adulta, aunque con resultados variables                                               los síndromes de Reinfenstein, Lubs, Rosewater y Gilbert-Dreyfus.\n              que dependen de múltiples factores, como la altura paterna, el inicio del tratamiento con                                               Las mutaciones en el gen del receptor de andrógenos se encuentran en la mayoría de los\n              GH, la dosis utilizada y la altura al inicio del tratamiento. En pacientes mayores de 10 años                                           individuos que tienen formas completas, pero es menos frecuente en individuos con for-\n              tratadas    con GH con       malas perspectivas de talla final se puede añadir al tratamiento la                                        mas parciales.\n              oxandrolona, que es un esteroide anabólico, en dosis de 0,03 a 0,05 mg/kg/día, lo que pue-\n              de mejorar su altura de 2 a 5 cm, aunque haya que vigilar sus posibles efectos virilizantes.                                            La diferenciación sexual depende de la presencia de andrógenos y de hormona antimülleriana\n                                                                                                                                                      en el periodo fetal cuando la gónada del embrión se diferencia a testículo a partir del día 42\n              Referencias:                                                                                                                            de gestación. La testosterona producida por las células de Leydig promueve la diferenciación\n              • Backeljauw P. Clinical manifestations and diagnosis of Turner syndrome. Snyder PJ, Firth HV, Geffner ME, eds. UpToDate. Waltham, MA:\n                UpToDate Inc. https://www.uptodate.com (Last updated: Apr 24, 2019.)                                                                  sexual masculina del conducto de Wolff en epidídimo, vasa deferentia y vesículas seminales.\n              • Shankar RK, Backeljauw PF. Current best practice in the management of Turner syndrome. Ther Adv Endocrinol Metab. 2018;9(1):33-40.    La conversión de testosterona en dihidrotestosterona por la enzima 5α-reductasa tipo 2 pro-\n                                                                                                                                                      mueve la diferenciación externa de los genitales masculinos. Problemas en la secreción o\n                                                                                                                                                      acción de los andrógenos alterarán el proceso de virilización.\n     6.4 Trastornos de la diferenciación sexual                                                                                                       La producción fetal de        hormona antimülleriana por parte de las células de S\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>TURNER SYNDROME<|>EVENT<|>Turner syndrome is a genetic condition characterized by the absence or alteration of one of the X chromosomes, leading to various physical and developmental issues, including short stature and gonadal insufficiency.)\n##\n(\"entity\"<|>KLINEFELTER SYNDROME<|>EVENT<|>Klinefelter syndrome is a genetic condition in males characterized by the presence of an extra X chromosome, which can lead to physical and reproductive abnormalities.)\n##\n(\"entity\"<|>ANDROGEN INSENSITIVITY SYNDROME<|>EVENT<|>Androgen insensitivity syndrome is a condition where individuals with XY chromosomes are resistant to androgens, leading to the development of female physical traits despite having male genetic makeup.)\n##\n(\"entity\"<|>SHOX GENE<|>ORGANIZATION<|>The SHOX gene is located on the X chromosome and is crucial for normal skeletal development; its absence can lead to short stature and other skeletal abnormalities.)\n##\n(\"entity\"<|>HORMONE RECEPTOR<|>ORGANIZATION<|>Hormone receptors are proteins that bind hormones and mediate their effects in the body; mutations in androgen receptors can lead to disorders of sexual development.)\n##\n(\"entity\"<|>GROWTH HORMONE<|>ORGANIZATION<|>Growth hormone is a peptide hormone that stimulates growth, cell reproduction, and regeneration; it is often used in treatment for individuals with growth deficiencies.)\n##\n(\"entity\"<|>OXANDROLONE<|>ORGANIZATION<|>Oxandrolone is an anabolic steroid that is used to promote weight gain in various conditions and can improve height in patients with growth hormone deficiencies.)\n##\n(\"entity\"<|>DIHYDROTESTOSTERONE<|>ORGANIZATION<|>Dihydrotestosterone is a potent androgen that plays a key role in the development of male external genitalia and secondary sexual characteristics.)\n##\n(\"relationship\"<|>TURNER SYNDROME<|>SHOX GENE<|>Turner syndrome is associated with the absence of the SHOX gene, which contributes to the condition's characteristic short stature<|>8)\n##\n(\"relationship\"<|>KLINEFELTER SYNDROME<|>ANDROGEN INSENSITIVITY SYNDROME<|>Both Klinefelter syndrome and androgen insensitivity syndrome involve abnormalities in sexual development due to genetic factors<|>5)\n##\n(\"relationship\"<|>ANDROGEN INSENSITIVITY SYNDROME<|>HORMONE RECEPTOR<|>Androgen insensitivity syndrome is caused by mutations in the androgen receptor gene, affecting the body's response to androgens<|>9)\n##\n(\"relationship\"<|>TURNER SYNDROME<|>GROWTH HORMONE<|>Growth hormone treatment is often indicated for individuals with Turner syndrome to improve adult height outcomes<|>7)\n##\n(\"relationship\"<|>GROWTH HORMONE<|>OXANDROLONE<|>Oxandrolone may be used in conjunction with growth hormone therapy to enhance height in patients with growth deficiencies<|>6)\n##\n(\"relationship\"<|>DIHYDROTESTOSTERONE<|>ANDROGEN INSENSITIVITY SYNDROME<|>Dihydrotestosterone is crucial for male genital development, and its action is disrupted in androgen insensitivity syndrome<|>8)\n<|COMPLETE|>"}]}